BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 31 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,575,560 | -19.9% | 2,600,000 | -18.8% | 0.00% | 0.0% |
| Q2 2023 | $3,216,992 | -59.2% | 3,200,000 | -57.7% | 0.00% | -50.0% |
| Q1 2023 | $7,885,156 | +46.6% | 7,560,000 | +51.0% | 0.00% | +33.3% |
| Q4 2022 | $5,378,173 | +8.2% | 5,005,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $4,970,000 | +99.7% | 5,005,000 | +99.8% | 0.00% | +200.0% |
| Q2 2022 | $2,489,000 | -15.9% | 2,505,000 | -15.3% | 0.00% | 0.0% |
| Q1 2022 | $2,961,000 | -4.0% | 2,957,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $3,084,000 | -71.9% | 2,957,000 | -73.0% | 0.00% | -80.0% |
| Q3 2021 | $10,979,000 | +24.3% | 10,971,000 | +24.5% | 0.01% | +25.0% |
| Q2 2021 | $8,830,000 | – | 8,813,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 55,306,226 | $54,866,518 | 2.72% |
| MACKAY SHIELDS LLC | 76,286,000 | $74,883,901 | 2.06% |
| Sonora Investment Management Group, LLC | 10,890,000 | $10,840,075 | 0.93% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 39,812,000 | $39,636,827 | 0.92% |
| BANQUE PICTET & CIE SA | 636,000 | $63,228,545 | 0.75% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,902,000 | $1,884,616 | 0.47% |
| LOOMIS SAYLES & CO L P | 2,074,551 | $183,557 | 0.32% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,015 | 0.28% |
| iA Global Asset Management Inc. | 14,690,000 | $14,625 | 0.24% |
| RATIONAL ADVISORS LLC | 1,803,000 | $1,786,052 | 0.16% |